BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BNT168 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BNT168\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07698600-996@assetmemo.bio
DTSTAMP:20261121T004538Z
DTSTART;VALUE=DATE:20280229
DTEND;VALUE=DATE:20280301
SUMMARY:BNT168: Phase 1 readout est. (NCT07698600)
DESCRIPTION:BNT168\, phase 1\, HIV.\nStudy: A Clinical Trial to Look at the
  Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Liv
 ing With or Without HIV\nEstimated primary completion: February 2028. This
  is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it 
 can move.\nDrug page: https://assetmemo.bio/drug/bnt168#upcoming-events\nR
 egistry record: https://clinicaltrials.gov/study/NCT07698600
URL:https://assetmemo.bio/drug/bnt168#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
